high dose oral semaglutide Wegovy approved for obesity management by FDA on December 23, 2025 Formulation: High‑dose oral (25 mg daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) Oral Semaglutide Gets FDA Approval

Anti-inflammatory effects: Some research suggests GLP-1 medications reduce chronic inflammation, which contributes to cardiovascular disease and other complications

Specific markers such as CD9, CD63, CD81, HSP70, and TSG101 are present on EV surfaces (Thery et al., 2002

Is Wegovy a prescription-only medicine

Semaglutide regulates your bodys hunger cues, food noise, and blood sugar for around 7 days, so we use weekly injections

The formula: Units to draw = (Dose in mg / Total mg in vial) x Total BAC water added in mL x 100 Worked examples for common vial and dose combinations Walk through three common scenarios: Scenario 1: 5mg vial, 2mg dose, 1mL BAC water added (2 / 5) x 1 x 100 = 40 units